Please read the PDF for clean formatting of the following wall of text , which I sent to the CEO, in clean formatting in the the PDF.
So I sent it to the CEO 2 weeks before a document on ethics was made public with a public filing.
Then around that time massive accumulation appeared to have started to happen.
The Uturn began the day they did the public filing on board ethics, and punishments for bad behavior.
---------------------------
Dear Doug Davis, VisionWave Holdings and Bannix Acquisition Corp have relied on over $3 million in insider loans and deferred obligations to finance your uplisting — capital fronted by insiders, sponsors, and private investors who fully expect this merger to proceed cleanly and compliantly. But let’s be blunt: This entire deal — the uplisting, the investor returns, the sponsors’ capital, your personal credibility — is being endangered by just one board member. That board member is Mr. Yossi Attia, and the conflict he has created now places the boards of VisionWave and Bannix at legal, reputational, and financial risk — unless it is addressed immediately. Mr. Attia does not need to be removed from his operational role — but the dual involvement in both the financing of GBT Technologies (GHTC) and the acquisition of its assets must end immediately. He can go from double-dealing to single-dealing, and retain his position so long as the toxic convertible note is formally canceled and any converted shares are rescinded through the appropriate SEC filings. 🚨 The potentially illegal, double-dealing conflict of interest • VisionWave is acquiring six patents from GHTC — forming the core intellectual property of its go-public strategy. • Simultaneously, GHTC’s share price has been driven down by a toxic, floorless convertible loan, facilitated or arranged by entities affiliated with Mr. Attia. • Mr. Attia is not only VisionWave’s Chief Operating Officer, but also manager of Stanley Hills LLC, the controlling shareholder post-merger. In effect, VisionWave is acquiring assets from a company being devalued by its own insider, while standing to benefit from the acquisition on the other end. This is not only unethical — it’s structurally identical to multiple SEC enforcement actions and will not survive regulatory or exchange scrutiny. ⚖️ One Rogue Director Is Now Jeopardizing Three Corporate Structures — and $25,000 in Monthly SPAC Survival Capital Let’s be blunt: One conflicted executive — Mr. Yossi Attia — is now threatening to unravel three interlinked companies, the capital they rely on, and the livelihoods of over a dozen individuals who’ve played by the rules. • VisionWave employs 9 total executives, including Mr. Attia. Most have invested years of time, energy, and reputation preparing for this uplisting. • BNIX (Bannix Acquisition Corp) has 2 VisionWave-linked board members and is currently depending on monthly $25,000 loans from sponsor Instant Fame LLC to keep the SPAC alive through its 27th extension, now running through June 14, 2025. • GHTC (GBT Technologies) is represented on the VisionWave board by 3 members and stands to gain from a long-awaited patent sale — unless it's derailed by a toxic loan tied to the same insider now acquiring their assets. This means 14 total directors and executives — across three companies — are now at reputational and financial risk because of the actions of just one conflicted actor. And now, that risk includes: • SPAC capital evaporating if Instant Fame LLC halts further deposits • SEC and Nasdaq scrutiny triggered by self-dealing and price suppression • Deal collapse wiping out investor confidence, GHTC’s IP value, and BNIX warrant upside 🧨 Final Point: The Stakes Are Real This isn’t theoretical. BNIX is actively borrowing $25,000 per month just to keep the merger alive. Allowing a self-interested director to sabotage that effort from within — while engineering dilution in GHTC — is not just a risk to reputations. It’s a risk to the entire capital structure. A clean, documented fix (canceling the convertibles, rescinding shares, limiting Mr. Attia’s financing role) preserves: • $30M+ in SPAC and sponsor value • $1.8M+ in BNIX warrant potential • A clean Nasdaq path for VisionWave • And GHTC’s shot at recovery and OTCQB uplisting Don’t let one person sink what three boards and over a dozen honest actors have worked to build. ✅ Simple Guideline: Here’s the Fix This situation can be fully addressed with one clear, reasonable plan: 1. Cancel all further conversions under the GHTC toxic note immediately. 2. Return all previously converted shares to GHTC’s treasury. 3. Announce the cancellation of those unlawful shares and reversal through the proper SEC filings: • GHTC 8-K (Item 1.02 + 3.02) • Form 4s for insider reversals • Updated S-4/A for VisionWave 4. Recuse Mr. Attia from all financing decisions and restrict him to operational oversight only. 📈 The Upside: OTCQB, Squeeze Potential — and a Public Win for Everyone Involved This isn’t just about cleanup — it’s an opportunity for all parties to win: • GHTC’s share price is currently $0.0001. Buying back the entire float would cost just ~$1.8 million — less than what’s already been invested in VisionWave’s SPAC structure. • BNIX warrants alone are worth more than $1.8 million — meaning your investor base has enough skin in the game to support a coordinated move. • Just by canceling dilution and buying back shares, GHTC could realistically reach $0.01+, a 10x move that would restore confidence. And if GHTC hits $0.10 and holds, it becomes eligible for OTCQB uplisting, bringing in a new tier of investors and legitimacy. In January 2021, (GME) famously soared from ~$17 to ~$500 during its historic short sque GameStop eze — a 2,841% return. By comparison, a move from $0.0001 to $0.1200 would represent a 119,900% return, turning a $1,000 investment into $1.2 million. While GME’s rally was unprecedented in mainstream equities, sub-penny stocks often move further under the right pressure. 👨🎤 Redemption Arc: From Conflict to Feel-Good Rally Here’s the twist: Even Mr. Attia could come out of this respected and market-loved — if he unwinds the conflict and embraces transparency. • His redemption arc becomes part of a retail investor success story, instead of a scandal narrative. • He remains in his operational role and benefits from both uplistings: • VisionWave ? Nasdaq • GHTC ? OTCQB ✅ Look at Ryan Cohen’s transformation with GameStop (GME): Once an outsider, he gained retail backing through transparency, direct engagement, and a clear vision — turning GME from a failing brick-and-mortar into a multi-billion dollar meme-fueled movement. ✅ Or Adam Aron of AMC: He leaned into the “Apes” movement, offered NFT perks, and embraced the retail base — helping AMC survive and flip into a cult stock, despite massive debt and dilution. ✅ Even BBBY’s turnaround attempt saw temporary rallies because of speculation around activist investors and restructuring transparency — despite fundamentals being shaky. Mr. Attia has that same opportunity: • Whitewash the conflict by ending the toxic financing structure. • Stand with retail and openly support a buyback or conversion freeze. • Allow the story to shift: from insider double-dealing ? to “Insider stands down, lets retail win, gets rewarded anyway.” In a market driven by narrative and trust, this shift could be more valuable than any single patent or financing round. \ 💡 Final Thought This can still be a win for everyone — insiders, SPAC sponsors, GHTC management, and the retail investors who’ve held through the volatility. But it requires one thing: fixing a conflict that never should’ve happened — and doing it transparently, before the window to act closes. This isn’t a scandal yet. It’s a single individual making a short-sighted move that now demands collective correction. That’s still a manageable situation — if it’s handled now. There’s no reason to let one director’s mistake collapse the uplisting, wipe out investor confidence, or put millions in deferred capital at risk. The fix is simple. The cost is minimal. The upside remains huge. Please don’t wait until this becomes irreversible. \ 🔗 Citations – Web Links. 1. VisionWave Holdings Inc. – Overview Deck Confirms Yossi Attia is the Chief Operating Officer. Excerpt: “Yossi Attia – COO Seasoned operational leader and entrepreneur with a strong track record in capital markets, venture growth, and international investment strategy. Brings extensive experience scaling businesses and driving cross-border execution.” 🔗 View Document (April 25, 2025) 2. Bannix Acquisition Corp. – Executive Profile (Yossi Attia) Yossi Attia is listed as a key executive with overlapping roles across related entities. As listed on the Wall Street Journal Market Data portal, Yossi Attia holds multiple roles in companies involved in the GHTC–VisionWave transaction: • Current Roles: • Director, Bannix Acquisition Corp. • President, Secretary, Treasurer & Director, VisionWave Technologies, Inc. • Regional Sales Director, Island Technology, Inc. 🔗 View on Wall Street Journal 3. SEC Filing – Attia’s Role with Stanley Hills, LLC Official SEC document confirming Yossi Attia is a manager of Stanley Hills, LLC. Excerpt: “ Stanley Hills, LLC (Acknowledging and Consenting) By: /s/ Yossi Attia Name: Yossi Attia Title: Manager Date: 2/4/25 🔗 View SEC Exhibit 10.4 4. OTC Markets Filing – Stanley Hills, LLC Disclosure Document listing Stanley Hills, LLC as an involved entity, showing overlap with Bannix and VisionWave through Yossi Attia. “ Potential IP’s Sale Effective as of March 20, 2024, GBT Tokenize Corp,entered into a Patent Purchase Agreement with VisionWave Technologies Inc. (“VisionWave”) pursuant to which VisionWave agreed to acquire from Tokenize the entire right, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and in motion objects (“VisionWave PPA”). The Purchase Price for the asset is $30,000,000 (the “Purchase Price”), which VisionWave will pay with shares of common stock, $0.0001 par value per share (the “Common Stock”). The Parties agree that the final Purchase Price may be adjusted and will be governed by a valuation report issued by a professional third party (“Valuation”). If the final Purchase Price per Valuation is less than $30,000,000, Tokenize has the option to cancel this Agreement. In accordance therewith, VisionWave agreed to issue and deliver to Tokenize, 1,000 shares of Common Stock (the “Shares”) representing 50% of VisionWave’s issued and outstanding shares of Common Stock, where the remainder of the 50% of VisionWave’s issued and outstanding shares of Common Stock are owned by a corporation controlled by Stanley Hills. Effective June 4, 2024 Tokenize been issued additional 222 shares from VisionWave for consideration of 10 million AVAI shares that been vested under VisionWave name. ” “Stanley Hills LLC – Toxic Convertible Note Summary 🗓️ Timeline & Loan Activity: • May–Dec 2019: Stanley Hills LLC loaned over $1,000,000 to GBT Technologies. • Feb 2020: A letter agreement allowed Stanley to convert $1,214,900 into GHTC shares at 85% of the lowest trading price over 20 days — a floorless, toxic convertible structure. • 2021: • Stanley converted $1.23M into 4.42M shares. • Loaned an additional $325,000. • Received SURG shares as partial repayment ($800,000). • Took over $424,731 in balances from another insider (Gonzalez). • Jan 2, 2023: Stanley issued a new convertible note to consolidate outstanding balances. Terms: • $750,000 principal • 10% interest • Maturity: Sept 30, 2024 • Same toxic 85% discount conversion formula ⚠️ December 31, 2024 — Major Amendment • Maturity extended to Dec 31, 2025 • Conversion price fixed at $0.00001 per share • Total principal adjusted to $600,000 • Max shares issuable: 60 billion • Resulting valuation risk: If fully converted, Stanley could own a massive portion of GHTC’s float, enabling dilution and price suppression. 📊 Conversions So Far • By Q4 2024: Stanley converted $170,000 into 2 billion GHTC shares. • Remaining debt (as of March 31, 2025): • Principal: $491,395 • Interest: $120,722 • Still convertible at $0.00001 — a clear overhang on the stock. 🔥 Why It Matters • This type of toxic, insider-connected financing mirrors previous SEC enforcement actions. • The insider's firm (Stanley Hills LLC) is also on the receiving end of the VisionWave patent deal. • The dual involvement means: • Suppression of GHTC’s stock via dilution • Acquisition of devalued IP at favorable terms • Regulatory red flags due to self-dealing and price manipulation ✅ Key Data Snapshot Category Value Loan Origination Total Advanced May–Dec 2019 ~$1.6M Fixed Conversion Rate (Dec 2024) $0.00001 Max Shares Issuable 60 billion Remaining Convertible Debt Related Insider “ 🔗 View Filing \ $491,395 Yossi Attia (Stanley Hills manager) ⚖️Citations – Glossary of Legal Precedents from Four Key SEC Cases ⚖️ 1. Breach of Fiduciary Duty ✅SEC v. CannTrust Holdings (2020) – Insiders suppressed value and transferred assets to controlled entities. ⚖️ 2. Securities Fraud – Rule 10b-5 ✅SEC v. Honig, Brauser et al. (2018) – Dilution + asset stripping by insiders through toxic instruments. ⚖️ 3. Failure to Disclose Conflicts ✅SEC v. Longfin Corp (2019) – Failure to disclose insider-connected deals sank the uplisting and triggered charges. ⚖️ 4. Unregistered Dealer Activity ✅SEC v. GPL Ventures (2021) – Floorless toxic notes, flipped for profit, led to enforcement and fines. \ ⚖️ Citation 1: SEC v. CannTrust Holdings (2020) ✅ SEC v. CannTrust Holdings (2020) – Insiders suppressed value and transferred assets to controlled entities. 📌 Summary In mid-2020, the SEC filed a complaint against CannTrust and select directors, alleging they made materially false and misleading statements about their regulatory compliance—specifically the use of unlicensed grow rooms. As a result, CannTrust’s stock price inflated until the truth emerged in July 2019, triggering a sharp market decline. The allegations included violations of Sections 10(b) and 20(a) of the Exchange Act and Sections 11, 12(a)(2), and 15 of the Securities Act. 🚨 Key Violations • Material misrepresentation: CannTrust’s statements to investors and Health Canada were misleading. • Fraudulent disclosure: The company suppressed information that would have significantly impacted investor decisions. ⚖️ Legal Outcomes • The firm settled via multiple class actions totaling approximately C$83 million. • The case underscored the severity of regulatory violations tied to false statements, with penalties reaching into the tens of millions. 🧠 Relevance to VisionWave / GHTC CannTrust shows that material misstatements and non- disclosure of internal issues—especially those affecting asset value—can result in devastating legal, financial, and reputational consequences. ⚖️ Citation 2: SEC v. Honig, Brauser et al. (2018) ✅SEC v. Honig, Brauser et al. (2018) — Market Manipulation via Toxic Financings 📌 Summary In September 2018, the SEC charged Barry Honig, Michael Brauser, John Stetson, John O’Rourke III, Mark Groussman, Phillip Frost, and others in a sweeping microcap pump-and-dump scheme involving: • Acquiring control of penny-stock companies through toxic PIPE financings • Issuing shares at steep discounts to insiders • Orchestrating coordinated stock promotions to pump prices • Dumping shares for $27+ million in profits ⚖️ Key Findings • Artificially inflated stock prices through secret promotions and manipulative trading • Immediate dumping of shares post-promotion for personal gain • Complex and coordinated efforts hidden from investors ⚖️ Legal Outcomes • Final judgments in March 2020 enjoined defendants from violating antifraud and disclosure provisions • Monetary penalties and penny-stock bars, with $1.1 million+ disgorgements per participant 🧠 Relevance to VisionWave / GHTC This case exemplifies how toxic financings, coordinated dilution, and insider control can manipulate penny-stock prices. Similar tactics are evident in GHTC’s toxic convertible notes, potentially enabling insiders to suppress value while benefiting from VisionWave transactions. ⚖️ Citation 3: SEC v. Longfin Corp (2019) ✅SEC v. Longfin Corp (2019) – Insider-connected deals sank the uplisting and triggered SEC charges. 📌 Summary The SEC charged Longfin Corp. for failing to disclose insider-connected transactions, which inflated its public float and misled Nasdaq and investors: • Issued over 2 million shares to insiders to meet float requirements • Sold those shares after hype-driven acquisition news • Failed to disclose the insider nature of those shares ⚖️ Legal Outcomes • SEC halted trading and froze proceeds • Fraud charges for unregistered insider sales and misleading float manipulation • Disgorgement funds pooled into a Fair Fund for investors 🧠 Relevance to VisionWave / GHTC Longfin’s failure to disclose insider ties and float manipulation mirrors concerns around GHTC’s note conversions and VisionWave’s acquisition of devalued assets. Such omissions can derail uplistings and lead to serious enforcement. ⚖️ Citation 4: SEC v. GPL Ventures (2021) ✅SEC v. GPL Ventures (2021) – Floorless toxic notes and unregistered dealer activity led to SEC enforcement. 📌 Summary GPL Ventures issued floorless convertible notes to microcap companies and: • Converted and dumped shares without SEC/FINRA registration • Engaged in paid promotions followed by rapid share sales • Faced $39M+ in penalties and penny-stock bars ⚖️ Key Parallels to GHTC • GHTC’s convertible notes have similar deep-discount terms • Massive dilution and billion-share conversions • Likely unregistered dealer activity and price suppression 🧠 Relevance to VisionWave / GHTC The SEC is actively targeting floorless note financing that harms investors. GHTC’s structure reflects many of the same red flags identified in the GPL Ventures case — suggesting potential for enforcement if unresolved.
Market Data 
Markets 
